Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Multiple Sclerosis - Relapsing Remitting
Type
Interventional
Phase
Phase 4
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 60 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03535298
Collaborators
University of Nottingham
Investigators
Principal Investigator: Daniel Ontaneda, MD, MSc The Cleveland Clinic Principal Investigator: Nikos Evangelou, MD, DPhil University of Nottingham